Gene Synthesis Companies to Develop Biothreat Protocols | GenomeWeb

NEW YORK (GenomeWeb News) – Five international synthetic genetics companies have started a consortium that will focus on developing best practices for biosecurity protocols.

The International Gene Synthesis Consortium (IGSC), made up of Blue Heron Biotechnology, DNA2.0, GeneArt, GenScript and Integrated DNA Technologies, said today that it will work with governments and other interested parties to support efforts to keep gene synthesis technologies from being misused.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.